Major pharma company to launch commercial catnip repellent by Q2 2027
Resolves: A press release or regulatory filing confirms the launch of a catnip-based mosquito repellent product by a major commercial entity.
user-generated· product
Major pharma company to launch commercial catnip repellent by Q2 2027
Market overview
A large pharmaceutical or consumer health company (e.g., Johnson & Johnson, Bayer, or a biotech firm) will announce a branded catnip-based mosquito repellent product, targeting global markets including Africa and Southeast Asia. This follows the demonstrated efficacy and growing demand for alternative repellents.
product prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2027-06-30
About this prediction
Resolution criteria
A press release or regulatory filing confirms the launch of a catnip-based mosquito repellent product by a major commercial entity.
Source: user-generated
More product markets
- Will Ocado partnership meet 35% productivity target? — 70% Yes
- Will DCI announce new EV contract worth >$50M? — 55% Yes
- Will the company announce a renewable energy contract by 2026-12-31? — 65% Yes
- Will enGene Therapeutics report positive interim data for DETAIL trial by Q1 2027? — 35% Yes
- Will Phase 2 enrollment reach 50/60 patients by 2026-12-31? — 90% Yes
- Will ServiceTitan announce a major AI partnership or acquisition by end of 2026? — 30% Yes
- Will fintech firms offering real-time fund verification see increased demand? — 75% Yes
- Will private label exceed 33% penetration by EOY? — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…